Literature DB >> 23642742

Aflibercept-related sterile inflammation.

Paul Hahn1, Judy E Kim, Sandra Stinnett, Mina M Chung, Pravin U Dugel, Harry W Flynn, Suber S Huang, Srinivas R Sadda, Tamer H Mahmoud.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23642742     DOI： 10.1016/j.ophtha.2012.11.018

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  16 in total

1.  Delayed onset panuveitis following intravitreal aflibercept injection.

Authors:  Jodi A Glading; Stewart R Lake; Jamie E Craig; Devaraj Supramaniam
Journal:  BMJ Case Rep       Date:  2014-06-11

2.  Brolucizumab-associated intraocular inflammation in eyes without retinal vasculitis.

Authors:  Andre J Witkin; Paul Hahn; Timothy G Murray; J Fernando Arevalo; Kevin J Blinder; Netan Choudhry; Geoff G Emerson; Roger A Goldberg; Stephen J Kim; Joel Pearlman; Eric W Schneider; Homayoun Tabandeh; Robert W Wong
Journal:  J Vitreoretin Dis       Date:  2020-12-15

3.  Intraocular pressure decreases in eyes with glaucoma-related diagnoses after conversion to aflibercept for treatment-resistant age-related macular degeneration.

Authors:  David J Ramsey; James C McCullum; Elise E Steinberger; Yubo Zhang; Amer Mosa Alwreikat; Michael L Cooper; Shiyoung Roh; Paul R Cotran
Journal:  Eye (Lond)       Date:  2021-08-12       Impact factor: 4.456

4.  Sterile Inflammation after Intravitreal Injection of Aflibercept in a Korean Population.

Authors:  Ju Young Kim; Yong Sung You; Oh Woong Kwon; Soon Hyun Kim
Journal:  Korean J Ophthalmol       Date:  2015-09-22

Review 5.  Ocular Infection: Endophthalmitis.

Authors:  Stephen G Schwartz; Harry W Flynn; Taraprasad Das; William F Mieler
Journal:  Dev Ophthalmol       Date:  2015-10-26

Review 6.  Mechanisms of sterile inflammation after intravitreal injection of antiangiogenic drugs: a narrative review.

Authors:  William J Anderson; Natasha Ferreira Santos da Cruz; Luiz Henrique Lima; Geoffrey G Emerson; Eduardo Büchele Rodrigues; Gustavo Barreto Melo
Journal:  Int J Retina Vitreous       Date:  2021-05-07

7.  Ziv-aflibercept in macular disease.

Authors:  Ahmad M Mansour; Sara I Al-Ghadban; Muhammad H Yunis; Marwan E El-Sabban
Journal:  Br J Ophthalmol       Date:  2015-02-12       Impact factor: 4.638

8.  Severe Ocular Inflammation Following Ranibizumab or Aflibercept Injections for Age-Related Macular Degeneration: A Retrospective Claims Database Analysis.

Authors:  Eric H Souied; Pravin U Dugel; Alberto Ferreira; Ron Hashmonay; Jingsong Lu; Simon P Kelly
Journal:  Ophthalmic Epidemiol       Date:  2016-02-08       Impact factor: 1.648

9.  Bilateral Severe Sterile Inflammation with Hypopyon after Simultaneous Intravitreal Triamcinolone Acetonide and Aflibercept Injection in a Patient with Bilateral Marked Rubeosis Associated with Ocular Ischemic Syndrome.

Authors:  Ceren Durmaz Engin; Ziya Ayhan; Süleyman Men; Aylin Yaman; A Osman Saatci
Journal:  Case Rep Ophthalmol Med       Date:  2017-03-13

Review 10.  Vitreous inflammation associated with intravitreal anti-VEGF pharmacotherapy.

Authors:  Shivi Agrawal; Malav Joshi; John B Christoforidis
Journal:  Mediators Inflamm       Date:  2013-11-06       Impact factor: 4.711
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.